A Chinese medicine composition for treating rheumatic bone disease and its preparation process
Through the bioactive composition extracted from plants such as Sophora ginseng, the toxic side effects and slow efficacy of existing drugs for treating rheumatic bone disease are solved, and the effects of antioxidant, anti-inflammatory and immune regulation are achieved, which significantly reduces the symptoms of rheumatic bone disease and Prevent the development of the disease.
Patent Information
- Application Number
- CN202311440026.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-11-01
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2043-11-01
AI Technical Summary
The existing drugs and Chinese medicine liniment for treating rheumatic bone diseases have problems such as severe toxic side effects, slow efficacy, long time and inability to completely cure stubborn diseases.
Alkaloids, styrene, volatile oils, saponins, saponins and fermentation-chlorophyll sodium products and probiotics extracted from plants such as Sophora pilosula, saponin, fermentation-chlorophyll sodium products, probiotics The combination of Yuanhe probiotic embedded particles and sulfasalazine is prepared by enzymatic fermentation and supercritical fluid extraction, which has the effects of antioxidant, anti-inflammatory and immunity regulation.
It significantly reduces the symptoms of rheumatic bone disease, improves joint damage and swelling, prevents and treats the development of the disease, and improves the persistence and safety of the treatment effect.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of traditional Chinese medicines, and in particular to a traditional Chinese medicine composition for treating rheumatic bone diseases and a preparation process thereof. Background Art
[0002] Rheumatic bone disease is mainly caused by poor blood circulation caused by cold, which leads to poor nutrition supply to muscles, ligaments, bursae and fascia. In addition to pain, joint lesions are also accompanied by swelling and movement disorders, showing a chronic course of alternating attacks and remissions. Some patients may also suffer from joint disability and visceral failure. Rheumatic bone disease is a chronic systemic disease that is difficult to cure. It starts slowly at the beginning. Patients first have prodromal symptoms such as fatigue, weight loss, poor appetite, low fever, and numbness and tingling in the hands and feet within a few weeks to a few months. Subsequently, joint pain, stiffness, warm skin around swelling, flushing, and automatic and passive movements cause pain. At first, one or two joints are affected, often migratory. Later, it develops into symmetrical polyarthritis starting from the small joints at the distal end of the limbs and then involving other joints. The second is the metacarpophalangeal, toe, wrist, knee, elbow, ankle, shoulder and hip joints, with morning joint stiffness and muscle soreness. As rheumatism and rheumatoid arthritis progress, patients develop irregular fever, rapid pulse, significant anemia, stiff and deformed joints, leading to disability. The knees, elbows, fingers, and wrists become fixed and flexed, and the fingers become subluxated outward. Patients lose the ability to take care of themselves and are bedridden all day, unable to move and in extreme pain.
[0003] At present, there are many drugs and methods for treating rheumatic bone diseases and joint pain. Western medicine preparations are mainly used to relieve pain and eliminate inflammation. They have large toxic and side effects and are not suitable for long-term use. They can only relieve pain but cannot completely cure the disease. Traditional Chinese medicine has many treatment methods for such diseases. In the existing technology, there are also many types of analgesic Chinese medicine ointments for rheumatic arthritis. Although they have certain therapeutic effects, they are slow to take effect and take a long time, and cannot achieve the expected therapeutic effect on patients with intractable diseases.
[0004] Chinese patent application CN1850192A discloses a pharmaceutical composition for treating sequelae of cerebral thrombosis and rheumatoid arthritis and a preparation method thereof. The pharmaceutical composition is composed of summer alkaloids, summer alkaloids, musk, herba scutellariae, millettia reticulata, clematis, processed aconite, angelica, stephania tetrandra, atractylodes, achyranthes bidentata, angelica dahurica, processed frankincense, processed myrrh, siler, drynaria, strychnos nux vomica, bombyx batryticatus, scorpion and the like. Although the pharmaceutical composition can relax muscles and tendons, promote blood circulation and relieve pain, it has a long course of treatment. Summary of the invention
[0005] The purpose of the present invention is to provide a Chinese medicine composition for treating rheumatic bone disease and its preparation process, which has good antioxidant, anti-inflammatory and immune regulation effects, improves rheumatic cold and heat arthralgia, reduces joint damage and joint swelling, effectively alleviates the symptoms of rheumatic bone disease, and prevents and treats the progression of the disease.
[0006] The technical solution of the present invention is achieved in this way:
[0007] The invention provides a preparation process of a traditional Chinese medicine composition for treating rheumatic bone disease. The invention comprises the following steps: uniformly mixing an alkaloid component obtained by extracting sophora flavescens and prepared aconitum kusnezoffii, a phenylpropanoid component obtained by extracting safflower, a volatile oil component obtained by extracting cinnamon bark and coix seeds, a gentiana macrophylla extract obtained by extracting gentiana macrophylla, a saponin component obtained by fermenting and extracting notoginseng and ginseng, a fermentation-sodium copper chlorophyllin product obtained by reacting the fermented drug residues with sodium copper chlorophyllin, embedded particles obtained by embedding prebiotics and probiotics, and sulfasalazine to prepare the traditional Chinese medicine composition for treating rheumatic bone disease.
[0008] As a further improvement of the present invention, the following steps are included:
[0009] S1. Preparation of alkaloid component: Sophora flavescens and Radix Aconiti Kusnezoffii were washed, dried, and crushed to obtain a mixed powder, added to a mixed solvent, heated for extraction, filtered, the solid residue was retained, the filtrate was concentrated, and purified by a strong acid cation exchange resin column, and the eluate of 12-20wt% hydrochloric acid solution was collected, extracted with chloroform, and the solvent was removed from the extract under reduced pressure to obtain an alkaloid component;
[0010] The mixed solvent is a mixture of chloroform, ethanol and ammonia water;
[0011] S2. Preparation of phenylpropanoid components: crush the thick vine, add it to an ethanol aqueous solution, add enzyme for enzymolysis, filter, retain the filter residue, recover ethanol from the filtrate, dry, dissolve the product in water, adjust the solution pH to 2.5-3.5, purify with NKA-9 macroporous resin, collect 50% of the ethanol eluate, recover ethanol, dry, and obtain phenylpropanoid components;
[0012] S3. Preparation of volatile oil components: Cinnamon bark and coix seed were washed, dried, crushed, and subjected to supercritical fluid extraction to obtain volatile oil components, and the solid was retained;
[0013] S4. Preparation of Gentiana macrophylla extract: The Gentiana macrophylla was washed, crushed, boiled and extracted with water, filtered, the solid residue was retained, the filtrate was added dropwise with aqueous ammonia to adjust the pH value of the solution to 9-10, heated for reaction, concentrated and refined with D101 macroporous adsorption resin, 30% and 60% ethanol eluates were collected, ethanol was recovered, and dried to obtain a Gentiana macrophylla extract;
[0014] S5. Preparation of saponin component: Wash Panax notoginseng and ginseng separately, dry, crush, add to water, add carbon source and nitrogen source, sterilize, inoculate Lactobacillus casei and Lactobacillus helveticus seed liquid, ferment and culture, filter, wash the solid residue with sterile water, collect the eluted bacterial liquid, concentrate the bacterial liquid to obtain concentrated bacterial liquid, concentrate the filtrate, purify with D101 macroporous adsorption resin, collect 45-50% ethanol eluate, recover ethanol, dry, and obtain saponin component;
[0015] S6. Enzymatic fermentation: the solid residues in step S1, step S2, step S3, step S4 and step S5 are mixed evenly, added into water, and enzymatically hydrolyzed with a composite enzyme, sterilized, inoculated with the concentrated bacterial solution obtained in step S6, enzymatically fermented, filtered, the solids are washed with sterile water, the eluted bacterial solution is collected, and freeze-dried to obtain probiotics; sodium copper chlorophyllin is added into the filtrate, stirred for reaction, dialyzed, and the dialyzate is freeze-dried to obtain a fermentation-sodium copper chlorophyllin product;
[0016] S7. Preparation of prebiotics: mixing inulin and carboxymethyl pachymaran to prepare prebiotics;
[0017] S8. Preparation of embedded particles: The probiotics prepared in step S6 and the prebiotics prepared in step S7 are mixed uniformly, added to water, sodium alginate and lecithin are added, and stirred to mix uniformly to obtain an aqueous phase; the aqueous phase is added to fish oil, emulsified, and calcium chloride solution is added dropwise, and solidified at room temperature to obtain embedded particles;
[0018] S9. Preparation of the composite: The embedded particles prepared in step S8 are mixed evenly with sulfasalazine to prepare a composite;
[0019] S10. Preparation of a Chinese medicine composition for treating rheumatic bone disease: uniformly mix the alkaloid component prepared in step S1, the phenylpropanoid component prepared in step S2, the volatile oil component prepared in step S3, the gentiana macrophylla extract prepared in step S4, the saponin component prepared in step S5, the fermentation-sodium copper chlorophyll product prepared in step S6, and the complex prepared in step S9 to prepare a Chinese medicine composition for treating rheumatic bone disease.
[0020] As a further improvement of the present invention, the mass ratio of Sophora flavescens and Radix Aconiti Kusnezoffii in step S1 is 7-10:12-15, the solid-liquid ratio of the mixed powder and the mixed solvent is 1:4-7g / mL, the mixed solvent is a mixed solution of chloroform, ethanol and ammonia water in a volume ratio of 3-5:2-3:1-1.2, the concentration of ammonia water is 20-22wt%, the temperature of the heating extraction is 40-50°C, the time is 2-4h, the strong acid cation exchange resin column is selected from at least one of D001, CD350, CD450, CD550, and CD650, and the concentration is concentrated to a relative density of 1.1-1.15; the solid-liquid ratio of Thick Rattan and ethanol aqueous solution in step S2 is 1:5-10g / mL, the concentration of the ethanol aqueous solution is 50-60wt%, the enzyme is cellulase, the addition amount is 1-2wt% of the total mass of the system, the temperature of the enzymolysis is 50-55°C, and the time is 0.5-1h.
[0021] As a further improvement of the present invention, the mass ratio of cinnamon bark to coix seed in step S3 is 2-4:7-10, and the conditions of supercritical fluid extraction are: extraction pressure: 25-30MPa, extraction temperature: 35-45°C, CO 2 Flow rate: 7-10L / h, extraction time: 1-3h, the entrainer is ethanol, and the addition amount is 1-2wt%; the solid-liquid ratio of Gentiana macrophylla and water in step S4 is 1:6-8g / mL, the boiling extraction time is 2-4h, the heating reaction temperature is 40-45°C, the time is 0.5-1h, and the concentration is concentrated to a relative density of 1.1-1.15.
[0022] As a further improvement of the present invention, the mass ratio of Panax notoginseng, ginseng, carbon source, nitrogen source and water in step S5 is 5-7:1-2:2-3:1-2:100, the carbon source is selected from at least one of glucose, sucrose, fructose and xylo-oligosaccharides, the nitrogen source is selected from at least one of fish bone meal, peptone, ammonium chloride, sodium nitrate, ammonium nitrate and potassium nitrate, and the bacterial content of the Lactobacillus casei and Lactobacillus helveticus seed liquid is 10 8 -10 9 cfu / mL, the inoculation amounts of the Lactobacillus casei and Lactobacillus helveticus seed solutions were 2-3 v / v% and 1-2 v / v%, respectively, the fermentation conditions were 36-38°C, 150-200 r / min, the fermentation was carried out for 36-48 h, and the bacterial content of the concentrated bacterial solution was 10 10 -10 11 cfu / mL, the concentration is concentrated to a relative density of 1.1-1.15; in step S6, the mass ratio of the solid residue in step S1, the solid residue in step S2, the solid residue in step S3, the solid residue in step S4, and the solid residue in step S5 is 5-7:2-4:2-3:3-5:3-5, the composite enzyme is a mixture of cellulase and pectinase, the mass ratio is 7-10:2-4, and the addition amount of the composite enzyme is 2% of the total mass of the system -4wt%, the temperature of the enzymatic hydrolysis is 40-45°C, the time is 1-3h, the inoculation amount of the concentrated bacterial liquid is 0.5-1v / v%, the conditions of the enzymatic fermentation are 37-40°C, 150-200r / min, the enzymatic fermentation culture is 36-48h, the mass ratio of the filtrate to sodium copper chlorophyllin is 1000:7-12, the stirring reaction time is 0.5-1h, and the pore size of the dialysis bag for dialysis is 1k-2kD.
[0023] As a further improvement of the present invention, the mass ratio of inulin and carboxymethyl tuckahoe polysaccharide in step S7 is 10-12:7-10; the mass ratio of probiotics, prebiotics, water, sodium alginate, lecithin and fish oil in step S8 is 5-7:3-5:150-200:12-15:0.5-1:300-350.
[0024] As a further improvement of the present invention, the mass ratio of the embedded particles to sulfasalazine in step S9 is 20-30:0.5-1; the mass ratio of the alkaloid component, phenylpropanoid component, volatile oil component, Gentiana macrophylla extract, saponin component, fermentation-sodium copper chlorophyllin product, and complex in step S10 is 5-7:3-5:1-2:3-5:4-6:7-10:12-15.
[0025] As a further improvement of the present invention, the present invention specifically comprises the following steps:
[0026] S1. Preparation of alkaloid component: 7-10 parts by weight of Sophora flavescens and 12-15 parts by weight of Radix Aconiti Kusnezoffii were washed, dried, and crushed to obtain a mixed powder, which was added to a mixed solvent, wherein the solid-liquid ratio of the mixed powder to the mixed solvent was 1:4-7 g / mL, heated to 40-50°C, extracted for 2-4 hours, filtered, the solid residue was retained, the filtrate was concentrated to a relative density of 1.1-1.15, and purified with a strong acid cation exchange resin column, and the eluent of 12-20wt% hydrochloric acid solution was collected, extracted with chloroform, and the solvent was removed from the extract under reduced pressure to obtain an alkaloid component;
[0027] The mixed solvent is a mixture of chloroform, ethanol and ammonia water in a volume ratio of 3-5:2-3:1-1.2, and the concentration of ammonia water is 20-22wt%;
[0028] S2. Preparation of phenylpropanoid components: crush thick vine, add it to 50-60wt% ethanol aqueous solution, the solid-liquid ratio of the thick vine and 50-60wt% ethanol aqueous solution is 1:5-10g / mL, add cellulase, the addition amount is 1-2wt% of the total mass of the system, enzymolysis at 50-55℃ for 0.5-1h, filter, retain the filter residue, recover ethanol from the filtrate, dry, dissolve 10 parts by weight of the product in 100 parts by weight of water, adjust the solution pH to 2.5-3.5, purify with NKA-9 macroporous resin, collect 50% of the ethanol eluate, recover ethanol, dry, and obtain phenylpropanoid components;
[0029] S3. Preparation of volatile oil component: 2-4 parts by weight of cinnamon, 7-10 parts by weight of coix seed were washed, dried, crushed, subjected to supercritical fluid extraction, the product was recovered by ethanol to obtain a volatile oil component, the solid was retained;
[0030] The conditions of supercritical fluid extraction are: extraction pressure: 25-30MPa, extraction temperature: 35-45°C, CO 2 Flow rate: 7-10 L / h, extraction time: 1-3 h, the entrainer is ethanol, and the addition amount is 1-2 wt%;
[0031] S4. Preparation of Gentiana macrophylla extract: Wash the Gentiana macrophylla, crush it, add water to mix, the solid-liquid ratio of the Gentiana macrophylla and water is 1:6-8g / mL, boil and extract for 2-4h, filter, retain the solid residue, add ammonia water to the filtrate to adjust the pH value of the solution to 9-10, heat to 40-45°C, stir and react for 0.5-1h, concentrate to a relative density of 1.1-1.15, purify with D101 macroporous adsorption resin, collect 30% and 60% ethanol eluates, combine the eluates, recover ethanol, dry, and obtain Gentiana macrophylla extract;
[0032] S5. Preparation of saponin component: 5-7 parts by weight of Panax notoginseng and 1-2 parts by weight of ginseng were washed, dried, crushed, added to 100 parts by weight of water, 2-3 parts by weight of carbon source, 1-2 parts by weight of nitrogen source were added, sterilized, inoculated with Lactobacillus casei and Lactobacillus helveticus seed solution, the inoculation amount was 2-3v / v% and 1-2v / v%, respectively, at 36-38°C, 150-200r / min, fermented and cultured for 36-48h, filtered, the solid residue was washed with sterile water, the eluted bacterial solution was collected, the bacterial solution was concentrated to obtain a concentrated bacterial solution, the filtrate was concentrated to a relative density of 1.1-1.15, refined by D101 macroporous adsorption resin, 45-50% of the ethanol eluate was collected, the ethanol was recovered, and dried to obtain a saponin component;
[0033] The bacterial content of the Lactobacillus casei and Lactobacillus helveticus seed liquid is 10 8 -10 9 cfu / mL;
[0034] S6. Enzymatic fermentation: 5-7 parts by weight of the solid residue in step S1, 2-4 parts by weight of the solid residue in step S2, 2-3 parts by weight of the solid residue in step S3, 3-5 parts by weight of the solid residue in step S4, and 3-5 parts by weight of the solid residue in step S5 are mixed evenly, added to 1000 parts by weight of water, and a composite enzyme is added, wherein the amount of the composite enzyme added is 2-4wt% of the total mass of the system, enzymolysis is carried out at 40-45°C for 1-3h, sterilized, and the concentrated solution obtained in step S6 is inoculated. The inoculation amount of the bacterial liquid is 0.5-1v / v%, 37-40°C, 150-200r / min, the enzymatic fermentation culture is carried out for 36-48h, the solid is filtered, the solid is washed with sterile water, the eluted bacterial liquid is collected, and the eluted bacterial liquid is freeze-dried to obtain probiotics; 7-12 parts by weight of sodium copper chlorophyllin are added to 1000 parts by weight of the filtrate, the reaction is stirred for 0.5-1h, the dialysis is performed with a pore size of 1k-2kD for 3-5h, and the dialyzate is freeze-dried to obtain a fermentation-sodium copper chlorophyllin product;
[0035] The complex enzyme is a mixture of cellulase and pectinase, with a mass ratio of 7-10:2-4;
[0036] S7. Preparation of prebiotics: 10-12 parts by weight of inulin and 7-10 parts by weight of carboxymethyl pachymaran were mixed to obtain prebiotics;
[0037] S8. Preparation of embedded particles: 5-7 parts by weight of the probiotics prepared in step S6 and 3-5 parts by weight of the prebiotics prepared in step S7 are mixed uniformly, added to 150-200 parts by weight of water, 12-15 parts by weight of sodium alginate and 0.5-1 parts by weight of lecithin are added, and stirred to obtain an aqueous phase; the aqueous phase is added to 300-350 parts by weight of fish oil, emulsified, 50 parts by weight of 3-5wt% calcium chloride solution is added dropwise, and cured at room temperature for 20-30min to obtain embedded particles;
[0038] S9. Preparation of the composite: 20-30 parts by weight of the embedded particles obtained in step S8 and 0.5-1 parts by weight of sulfasalazine were mixed uniformly to obtain a composite;
[0039] S10. Preparation of a traditional Chinese medicine composition for treating rheumatic bone diseases: 5-7 parts by weight of the alkaloid component prepared in step S1, 3-5 parts by weight of the phenylpropanoid component prepared in step S2, 1-2 parts by weight of the volatile oil component prepared in step S3, 3-5 parts by weight of the gentiana macrophylla extract prepared in step S4, 4-6 parts by weight of the saponin component prepared in step S5, 7-10 parts by weight of the fermentation-sodium copper chlorophyll product prepared in step S6, and 12-15 parts by weight of the complex prepared in step S9 are mixed uniformly to prepare a traditional Chinese medicine composition for treating rheumatic bone diseases.
[0040] The present invention further protects a traditional Chinese medicine composition for treating rheumatic bone disease prepared by the above preparation method.
[0041] The present invention further protects the use of the above-mentioned traditional Chinese medicine composition for treating rheumatic bone diseases in the preparation of medicines for treating or assisting in treating rheumatic bone diseases.
[0042] The present invention has the following beneficial effects:
[0043] The traditional Chinese medicine composition for treating rheumatic bone disease of the present invention comprises an alkaloid component extracted from sophora flavescens and prepared aconite, a phenylpropanoid component extracted from thick vine, a volatile oil component extracted from cinnamon bark and coix seed, a gentiana macrophylla extract extracted from gentiana macrophylla, a saponin component extracted from fermentation of panax notoginseng and ginseng, a fermentation-sodium copper chlorophyllin product obtained by reacting the above-mentioned medicinal residues with sodium copper chlorophyllin after fermentation, embedded particles obtained by embedding prebiotics and probiotics, and sulfasalazine. The prepared traditional Chinese medicine composition for treating rheumatic bone disease has good antioxidant, anti-inflammatory and immunity regulating effects, improves rheumatic cold and heat arthralgia, alleviates joint damage and joint swelling, effectively alleviates the symptoms of rheumatic bone disease, and prevents and treats the progression of the disease.
[0044] Among them, Thick Teng has the effects of dispelling wind and dampness, eliminating carbuncle and dispersing nodules, removing toxins and reducing swelling. The extracted phenylpropanoid components such as eugenol and 4-vinylguaiacol can significantly inhibit the synthesis of prostaglandins. Its anti-inflammatory mechanism may be related to inhibiting leukocyte chemotaxis, preventing leukocytes from producing oxygen free radicals, inhibiting carrageenan-induced plantar swelling, ear swelling and prostaglandin synthesis in mice, improving rheumatic cold and heat arthritis joint injuries, reducing joint swelling, and inhibiting the production of inflammatory factors in serum.
[0045] The processed Radix Aconiti Kusnezoffii has the effects of dispelling wind and dampness, warming the meridians and relieving pain. Its main ingredients, aconitum alkaloids, including aconitine and neoaconitine, have analgesic, anti-inflammatory, immune-regulating and anti-tumor effects, and inhibit prostaglandin E2 (PGE 2 ) synthesis, reduce capillary permeability, antagonize inflammatory mediators and cytokines, aconitine, neoaconitine, etc. can be used as Na + It is an activator of the channel and binds to its channel binding site, causing it to depolarize and block pain transmission. Aconitine can inhibit T cells and their subsets, thereby indirectly inhibiting the differentiation of B cells, and exerting a regulatory effect on cellular immunity and humoral immunity.
[0046] Matrine, an alkaloid in Sophora flavescens, has antiviral, anti-inflammatory and immune-regulating effects. It can reduce tenderness in patients with rheumatic bone diseases, lower the level of inflammatory factors, inhibit the phosphatidylinositol 3-kinase / protein kinase B signaling pathway, inhibit collagen-induced arthritis synovial angiogenesis, and promote synovial cell apoptosis.
[0047] The volatile oil extracted from coix seed and cinnamon bark can promote cellular immunity and humoral immunity, and also has anti-inflammatory effects.
[0048] Qinjiao contains a large amount of gentiopicroside, which can inhibit the ear swelling of mice caused by xylene and the increased permeability of mouse abdominal capillaries caused by acetic acid. It has a certain inhibitory effect on the early exudation of inflammation and has a sustained analgesic effect. Its diuretic effect is beneficial to the excretion of uric acid. At the same time, during the extraction process, gentiopicroside can react with ammonia to obtain the alkaloid gentianine A, which can reduce joint swelling and further improve the anti-rheumatic effect.
[0049] Notoginseng and ginseng are rich in saponins. At the same time, through the fermentation of fermentation bacteria, ordinary saponins can be transformed into highly active rare saponins. Among them, notoginseng saponin R1, ginsenoside Rg1, Rg3, and Rh2 can inhibit the activation of the MAPK / ERK pathway, limit the release of inflammatory factors interleukin-6 (IL-6) and IL-1β, inhibit the synthesis of metalloproteinases in joint tissues, reduce inflammatory reactions, and slow down the degradation of articular cartilage, thereby alleviating the condition of rheumatic bone disease. Notoginseng total saponins can slow down the rate of intervertebral disc degeneration through the regulation of the IL-1β / NF-KB signaling pathway. The synergistic effect of notoginseng saponins and ginsenosides can play an anti-inflammatory, antibacterial, inhibit platelet aggregation, improve microcirculation, resist free radical damage, resist thrombosis, improve bone and joint microcirculation, and promote injury repair.
[0050] Probiotics can help form a thicker mucosal barrier to resist pathogens and inhibit the production of serum amyloid protein A, tumor necrosis factor α and fibrinogen by regulating the intestinal flora, thereby improving the condition of rheumatic bone disease. Intake of Lactobacillus casei can reduce the secretion of IL-10, tumor necrosis factor α, and IL-12, and intake of Lactobacillus helveticus can significantly reduce the level of antigen-specific IgG and inflammatory response, inhibit the progression of rheumatic bone disease, and further alleviate the condition. The two have a synergistic effect. At the same time, by adding prebiotics, the intestinal flora structure of patients with rheumatic bone disease can be changed, and the production of short-chain fatty acids such as butyrate and propionate by intestinal bacteria can be increased. It has an immunomodulatory effect and can indirectly improve the condition of rheumatic bone disease. In addition, prebiotics, including inulin and carboxymethyl tuckahoe polysaccharide, can also form a shell layer of the embedded particles together with sodium alginate, enhance the ability of the embedded particles to resist gastric acid and choline, thereby ensuring that the probiotics can smoothly reach the intestines, and the prebiotics are also used by the probiotics in the intestines, thus playing a good regulatory role.
[0051] In addition, although the sulfasalazine added to the complex has no direct activity in the intestine, it can stimulate the intestinal microbiome gene-encoded azoreductase to cut the NN double bond and release active 5-aminosalicylic acid after reaching the distal intestine, achieving anti-inflammatory effects. At the same time, sulfasalazine can induce the expression of intestinal microbiome gene clusters, encoding thioredoxin reductase and nitrate reductase. Thioredoxin reductase can inhibit hydrogen peroxide from inhibiting the apoptosis of synovial cells in patients with rheumatic bone disease, thereby improving the symptoms of joint pain in patients with rheumatic bone disease. DETAILED DESCRIPTION
[0052] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0053] Cellulase, 10,000 U / g, and pectinase, 8,000 U / g, were purchased from Jiangsu Caiwei Biotechnology Co., Ltd.
[0054] Lactobacillus casei, 10 billion cfu / g, was purchased from Weikai Haisi (Shandong) Bioengineering Co., Ltd.; Lactobacillus helveticus, 10 billion cfu / g, was purchased from Jiangsu Caiwei Biotechnology Co., Ltd.
[0055] Preparation of Lactobacillus casei and Lactobacillus helveticus seed solution: Lactobacillus casei and Lactobacillus helveticus were inoculated into Gould's medium respectively, and fermented at 37°C, 100 r / min, for 24 h to obtain seed solution containing 10 8 -10 9 cfu / mL.
[0056] Example 1
[0057] This embodiment provides a preparation process of a Chinese medicine composition for treating rheumatic bone disease, which specifically comprises the following steps:
[0058] S1. Preparation of alkaloid component: 7 parts by weight of Sophora flavescens and 12 parts by weight of Radix Aconiti Kusnezoffii were washed, dried, and crushed to obtain a mixed powder, which was added to a mixed solvent, wherein the solid-liquid ratio of the mixed powder to the mixed solvent was 1:4 g / mL, heated to 40°C, extracted for 2 hours, filtered, the solid residue was retained, the filtrate was concentrated to a relative density of 1.1, purified with a D001 cation exchange resin column, and the eluate of 12 wt% hydrochloric acid solution was collected, extracted with chloroform, and the solvent was removed from the extract under reduced pressure to obtain an alkaloid component;
[0059] The mixed solvent is a mixture of chloroform, ethanol and ammonia water in a volume ratio of 3:2:1, and the concentration of ammonia water is 20wt%;
[0060] S2. Preparation of phenylpropanoid components: crush thick vine, add it to a 50wt% ethanol aqueous solution, the solid-liquid ratio of the thick vine and the 50wt% ethanol aqueous solution is 1:5g / mL, add cellulase, the addition amount is 1wt% of the total mass of the system, enzymolysis is carried out at 50℃ for 0.5h, filter, retain the filter residue, recover ethanol from the filtrate, dry, dissolve 10 parts by weight of the product in 100 parts by weight of water, adjust the solution pH to 2.5, purify with NKA-9 macroporous resin, collect 50% of the ethanol eluate, recover ethanol, dry, and obtain phenylpropanoid components;
[0061] S3. Preparation of volatile oil component: 2 parts by weight of cinnamon and 7 parts by weight of coix seed were washed, dried, crushed, and subjected to supercritical fluid extraction, the product was recovered by ethanol to obtain a volatile oil component, and the solid was retained;
[0062] The conditions of the supercritical fluid extraction are: extraction pressure: 25 MPa, extraction temperature: 35°C, CO 2 Flow rate: 7 L / h, extraction time: 1 h, the entrainer is ethanol, and the addition amount is 1 wt%;
[0063] S4. Preparation of Gentiana macrophylla extract: Wash Gentiana macrophylla, crush it, add water to mix, the solid-liquid ratio of Gentiana macrophylla and water is 1:6 g / mL, boil and extract for 2 hours, filter, retain the solid residue, add ammonia water to the filtrate to adjust the pH value of the solution to 9, heat to 40°C, stir and react for 0.5 hours, concentrate to a relative density of 1.1, purify with D101 macroporous adsorption resin, collect 30% and 60% ethanol eluates, combine the eluates, recover ethanol, dry, and obtain Gentiana macrophylla extract;
[0064] S5. Preparation of saponin component: 5 parts by weight of Panax notoginseng and 1 part by weight of ginseng were washed, dried, crushed, added to 100 parts by weight of water, 2 parts by weight of glucose and 1 part by weight of ammonium chloride were added, sterilized, inoculated with Lactobacillus casei and Lactobacillus helveticus seed liquid, the inoculation amount was 2v / v% and 1v / v%, respectively, at 36°C, 150r / min, fermented and cultured for 36h, filtered, the solid residue was washed with sterile water, the eluted bacterial solution was collected, the bacterial solution was concentrated to obtain a concentrated bacterial solution, the filtrate was concentrated to a relative density of 1.1, refined by D101 macroporous adsorption resin, 45% of the ethanol eluate was collected, the ethanol was recovered, and dried to obtain a saponin component;
[0065] S6. Enzymatic fermentation: 5 parts by weight of the solid residue in step S1, 2 parts by weight of the solid residue in step S2, 2 parts by weight of the solid residue in step S3, 3 parts by weight of the solid residue in step S4, and 3 parts by weight of the solid residue in step S5 are mixed evenly, added to 1000 parts by weight of water, and a composite enzyme is added, wherein the amount of the composite enzyme added is 2wt% of the total mass of the system, and enzymatic hydrolysis is performed at 40°C for 1 hour, sterilized, and the concentrated bacterial solution obtained in step S6 is inoculated with an inoculation amount of 0.5v / v%, 37°C, 150r / min, and enzymatic fermentation is cultured for 36 hours, filtered, and the solid is washed with sterile water. The eluted bacterial solution is collected and freeze-dried to obtain probiotics; 7 parts by weight of sodium copper chlorophyllin is added to 1000 parts by weight of the filtrate, the reaction is stirred for 0.5 hours, dialyzed with a pore size of 1kD for 3 hours, and the dialyzate is freeze-dried to obtain a fermentation-sodium copper chlorophyllin product;
[0066] The complex enzyme is a mixture of cellulase and pectinase, with a mass ratio of 7:2;
[0067] S7. Preparation of prebiotics: 10 parts by weight of inulin and 7 parts by weight of carboxymethyl pachymaran were stirred and mixed for 10 min to prepare prebiotics;
[0068] S8. Preparation of embedded particles: 5 parts by weight of the probiotics prepared in step S6 and 3 parts by weight of the prebiotics prepared in step S7 were mixed uniformly, added to 150 parts by weight of water, 12 parts by weight of sodium alginate and 0.5 parts by weight of lecithin were added, and stirred for 10 minutes to obtain an aqueous phase; the aqueous phase was added to 300 parts by weight of fish oil, emulsified at 10000 r / min for 10 minutes, 50 parts by weight of 3wt% calcium chloride solution was added dropwise, and cured at room temperature for 20 minutes to obtain embedded particles;
[0069] S9. Preparation of the composite: 20 parts by weight of the embedded particles obtained in step S8 were stirred and mixed with 0.5 parts by weight of sulfasalazine for 10 min to obtain a composite;
[0070] S10. Preparation of a Chinese medicine composition for treating rheumatic bone diseases: 5 parts by weight of the alkaloid component prepared in step S1, 3 parts by weight of the phenylpropanoid component prepared in step S2, 1 part by weight of the volatile oil component prepared in step S3, 3 parts by weight of the gentiana macrophylla extract prepared in step S4, 4 parts by weight of the saponin component prepared in step S5, 7 parts by weight of the fermentation-sodium copper chlorophyll product prepared in step S6, and 12 parts by weight of the complex prepared in step S9 are stirred and mixed for 20 minutes to prepare a Chinese medicine composition for treating rheumatic bone diseases.
[0071] Example 2
[0072] This embodiment provides a preparation process of a Chinese medicine composition for treating rheumatic bone disease, which specifically comprises the following steps:
[0073] S1. Preparation of alkaloid component: 10 parts by weight of Sophora flavescens and 15 parts by weight of Radix Aconiti Kusnezoffii were washed, dried, and crushed to obtain a mixed powder, which was added to a mixed solvent, wherein the solid-liquid ratio of the mixed powder to the mixed solvent was 1:7 g / mL, heated to 50°C, extracted for 4 hours, filtered, the solid residue was retained, the filtrate was concentrated to a relative density of 1.15, purified with a D001 cation exchange resin column, and the eluate of 20 wt% hydrochloric acid solution was collected, extracted with chloroform, and the solvent was removed from the extract under reduced pressure to obtain an alkaloid component;
[0074] The mixed solvent is a mixture of chloroform, ethanol and ammonia water in a volume ratio of 5:3:1.2, and the concentration of ammonia water is 22wt%;
[0075] S2. Preparation of phenylpropanoid components: crush thick vine, add it to a 60wt% ethanol aqueous solution, the solid-liquid ratio of the thick vine and the 60wt% ethanol aqueous solution is 1:10g / mL, add cellulase, the addition amount is 2wt% of the total mass of the system, enzymolysis is carried out at 55°C for 1h, filter, retain the filter residue, recover ethanol from the filtrate, dry, dissolve 10 parts by weight of the product in 100 parts by weight of water, adjust the solution pH to 3.5, purify with NKA-9 macroporous resin, collect 50% of the ethanol eluate, recover ethanol, dry, and obtain phenylpropanoid components;
[0076] S3. Preparation of volatile oil component: 4 parts by weight of cinnamon and 10 parts by weight of coix seed were washed, dried, crushed, and subjected to supercritical fluid extraction, and the product was recovered by ethanol to obtain a volatile oil component, and the solid was retained;
[0077] The conditions of the supercritical fluid extraction are: extraction pressure: 30 MPa, extraction temperature: 45°C, CO 2 Flow rate: 10 L / h, extraction time: 3 h, the entrainer is ethanol, and the addition amount is 2 wt%;
[0078] S4. Preparation of Gentiana macrophylla extract: Wash Gentiana macrophylla, crush it, add water to mix, the solid-liquid ratio of Gentiana macrophylla and water is 1:8 g / mL, boil and extract for 4 hours, filter, retain the solid residue, add ammonia water to the filtrate to adjust the pH value of the solution to 10, heat to 45°C, stir and react for 1 hour, concentrate to a relative density of 1.15, purify with D101 macroporous adsorption resin, collect 30% and 60% ethanol eluates, combine the eluates, recover ethanol, dry, and obtain Gentiana macrophylla extract;
[0079] S5. Preparation of saponin component: 7 parts by weight of Panax notoginseng and 2 parts by weight of ginseng were washed, dried, crushed, added to 100 parts by weight of water, 3 parts by weight of fructose and 2 parts by weight of fish bone powder were added, sterilized, inoculated with Lactobacillus casei and Lactobacillus helveticus seed liquid, the inoculation amount was 3v / v% and 2v / v%, respectively, at 38°C, 200r / min, fermented and cultured for 48h, filtered, the solid residue was washed with sterile water, the eluted bacterial solution was collected, the bacterial solution was concentrated to obtain a concentrated bacterial solution, the filtrate was concentrated to a relative density of 1.15, refined by D101 macroporous adsorption resin, 50% of the ethanol eluate was collected, the ethanol was recovered, and dried to obtain a saponin component;
[0080] S6. Enzymatic fermentation: 7 parts by weight of the solid residue in step S1, 4 parts by weight of the solid residue in step S2, 3 parts by weight of the solid residue in step S3, 5 parts by weight of the solid residue in step S4, and 5 parts by weight of the solid residue in step S5 are mixed evenly, added to 1000 parts by weight of water, and a composite enzyme is added, wherein the amount of the composite enzyme added is 4wt% of the total mass of the system, and enzymatic hydrolysis is performed at 45°C for 3h, sterilized, and the concentrated bacterial solution obtained in step S6 is inoculated with an inoculation amount of 1v / v%, 40°C, 200r / min, and enzymatic fermentation is cultured for 48h, filtered, and the solid is washed with sterile water. The eluted bacterial solution is collected and freeze-dried to obtain probiotics; 12 parts by weight of sodium copper chlorophyllin is added to 1000 parts by weight of the filtrate, the reaction is stirred for 1h, dialyzed with a pore size of 2kD for 5h, and the dialyzate is freeze-dried to obtain a fermentation-sodium copper chlorophyllin product;
[0081] The complex enzyme is a mixture of cellulase and pectinase, with a mass ratio of 10:4;
[0082] S7. Preparation of prebiotics: 12 parts by weight of inulin and 10 parts by weight of carboxymethyl pachymaran were stirred and mixed for 10 min to prepare prebiotics;
[0083] S8. Preparation of embedded particles: 7 parts by weight of the probiotics prepared in step S6 and 5 parts by weight of the prebiotics prepared in step S7 were mixed uniformly, added to 200 parts by weight of water, 15 parts by weight of sodium alginate and 1 part by weight of lecithin were added, and stirred for 10 minutes to obtain an aqueous phase; the aqueous phase was added to 350 parts by weight of fish oil, emulsified at 10000 r / min for 10 minutes, 50 parts by weight of 5wt% calcium chloride solution was added dropwise, and cured at room temperature for 30 minutes to obtain embedded particles;
[0084] S9. Preparation of the composite: 30 parts by weight of the embedded particles obtained in step S8 and 1 part by weight of sulfasalazine were stirred and mixed for 10 min to obtain a composite;
[0085] S10. Preparation of a traditional Chinese medicine composition for treating rheumatic bone diseases: 7 parts by weight of the alkaloid component prepared in step S1, 5 parts by weight of the phenylpropanoid component prepared in step S2, 2 parts by weight of the volatile oil component prepared in step S3, 5 parts by weight of the gentiana macrophylla extract prepared in step S4, 6 parts by weight of the saponin component prepared in step S5, 10 parts by weight of the fermentation-sodium copper chlorophyll product prepared in step S6, and 15 parts by weight of the complex prepared in step S9 are stirred and mixed for 20 minutes to prepare a traditional Chinese medicine composition for treating rheumatic bone diseases.
[0086] Example 3
[0087] This embodiment provides a preparation process of a Chinese medicine composition for treating rheumatic bone disease, which specifically comprises the following steps:
[0088] S1. Preparation of alkaloid component: 8 parts by weight of Sophora flavescens and 13 parts by weight of Radix Aconiti Kusnezoffii were washed, dried, and crushed to obtain a mixed powder, which was added to a mixed solvent, wherein the solid-liquid ratio of the mixed powder to the mixed solvent was 1:5 g / mL, heated to 45°C, extracted for 3 hours, filtered, the solid residue was retained, the filtrate was concentrated to a relative density of 1.12, purified with a D001 cation exchange resin column, and the eluate of 16 wt% hydrochloric acid solution was collected, extracted with chloroform, and the solvent was removed from the extract under reduced pressure to obtain an alkaloid component;
[0089] The mixed solvent is a mixture of chloroform, ethanol and ammonia water in a volume ratio of 4:2.5:1.1, and the concentration of ammonia water is 21wt%;
[0090] S2. Preparation of phenylpropanoid components: crush thick vine, add it to 55wt% ethanol aqueous solution, the solid-liquid ratio of thick vine and 55wt% ethanol aqueous solution is 1:7g / mL, add cellulase, the addition amount is 1.5wt% of the total mass of the system, enzymolysis at 52℃ for 1h, filter, retain the filter residue, recover ethanol from the filtrate, dry, dissolve 10 parts by weight of the product in 100 parts by weight of water, adjust the solution pH to 3, purify with NKA-9 macroporous resin, collect 50% of the ethanol eluate, recover ethanol, dry, and obtain phenylpropanoid components;
[0091] S3. Preparation of volatile oil component: 3 parts by weight of cinnamon and 8 parts by weight of coix seed were washed, dried, crushed, and subjected to supercritical fluid extraction, the product was recovered by ethanol to obtain a volatile oil component, and the solid was retained;
[0092] The conditions of the supercritical fluid extraction are: extraction pressure: 27 MPa, extraction temperature: 40°C, CO 2 Flow rate: 8 L / h, extraction time: 2 h, the entrainer is ethanol, and the addition amount is 1.2 wt%;
[0093] S4. Preparation of Gentiana macrophylla extract: Wash Gentiana macrophylla, crush it, add water to mix, the solid-liquid ratio of Gentiana macrophylla and water is 1:7 g / mL, boil and extract for 3 hours, filter, retain the solid residue, add ammonia water to the filtrate to adjust the pH value of the solution to 9.5, heat to 42°C, stir and react for 1 hour, concentrate to a relative density of 1.12, purify with D101 macroporous adsorption resin, collect 30% and 60% ethanol eluates, combine the eluates, recover ethanol, dry, and obtain Gentiana macrophylla extract;
[0094] S5. Preparation of saponin component: 6 parts by weight of Panax notoginseng and 1.5 parts by weight of ginseng were washed, dried, crushed, added to 100 parts by weight of water, 2.5 parts by weight of sucrose and 1.5 parts by weight of ammonium nitrate were added, sterilized, inoculated with Lactobacillus casei and Lactobacillus helveticus seed liquid, the inoculation amount was 2.5v / v% and 1.5v / v%, respectively, at 37°C, 170r / min, fermented and cultured for 42h, filtered, the solid residue was washed with sterile water, the eluted bacterial solution was collected, the bacterial solution was concentrated to obtain a concentrated bacterial solution, the filtrate was concentrated to a relative density of 1.12, refined by D101 macroporous adsorption resin, 47% of the ethanol eluate was collected, the ethanol was recovered, and dried to obtain a saponin component;
[0095] S6. Enzymatic fermentation: 6 parts by weight of the solid residue in step S1, 3 parts by weight of the solid residue in step S2, 2.5 parts by weight of the solid residue in step S3, 4 parts by weight of the solid residue in step S4, and 4 parts by weight of the solid residue in step S5 are mixed evenly, added to 1000 parts by weight of water, and a composite enzyme is added, wherein the amount of the composite enzyme added is 3wt% of the total mass of the system, and enzymatic hydrolysis is performed at 42°C for 2h, sterilized, and the concentrated bacterial solution obtained in step S6 is inoculated with an inoculation amount of 0.7v / v%, 38°C, 170r / min, and enzymatic fermentation is cultured for 42h, filtered, and the solid is washed with sterile water. The eluted bacterial solution is collected and freeze-dried to obtain probiotics; 10 parts by weight of sodium copper chlorophyllin is added to 1000 parts by weight of the filtrate, the reaction is stirred for 1h, dialyzed with a pore size of 1.5kD for 4h, and the dialyzate is freeze-dried to obtain a fermentation-sodium copper chlorophyllin product;
[0096] The complex enzyme is a mixture of cellulase and pectinase, with a mass ratio of 8:3;
[0097] S7. Preparation of prebiotics: 11 parts by weight of inulin and 9 parts by weight of carboxymethyl pachymaran were stirred and mixed for 10 min to prepare prebiotics;
[0098] S8. Preparation of embedded particles: 6 parts by weight of the probiotics prepared in step S6 and 4 parts by weight of the prebiotics prepared in step S7 were mixed uniformly, added to 170 parts by weight of water, 13 parts by weight of sodium alginate and 0.7 parts by weight of lecithin were added, and stirred for 10 minutes to obtain an aqueous phase; the aqueous phase was added to 320 parts by weight of fish oil, emulsified at 10000 r / min for 10 minutes, 50 parts by weight of 4wt% calcium chloride solution was added dropwise, and cured at room temperature for 25 minutes to obtain embedded particles;
[0099] S9. Preparation of the composite: 25 parts by weight of the embedded particles obtained in step S8 were stirred and mixed with 0.7 parts by weight of sulfasalazine for 10 min to obtain a composite;
[0100] S10. Preparation of a traditional Chinese medicine composition for treating rheumatic bone diseases: 6 parts by weight of the alkaloid component prepared in step S1, 4 parts by weight of the phenylpropanoid component prepared in step S2, 1.5 parts by weight of the volatile oil component prepared in step S3, 4 parts by weight of the gentiana macrophylla extract prepared in step S4, 5 parts by weight of the saponin component prepared in step S5, 8 parts by weight of the fermentation-sodium copper chlorophyll product prepared in step S6, and 13 parts by weight of the complex prepared in step S9 are stirred and mixed for 20 minutes to prepare a traditional Chinese medicine composition for treating rheumatic bone diseases.
[0101] Example 4
[0102] Compared with Example 3, the difference is that the composite enzyme is a single cellulase.
[0103] Example 5
[0104] Compared with Example 3, the difference is that the complex enzyme is a single pectinase.
[0105] Comparative Example 1
[0106] Compared with Example 3, the difference is that no Sophora flavescens is added in step S1.
[0107] The details are as follows:
[0108] S1. Preparation of alkaloid component: 21 parts by weight of prepared Aconitum kusnezoffii were washed, dried, crushed to obtain powder, added to a mixed solvent, the solid-liquid ratio of the powder to the mixed solvent was 1:5 g / mL, heated to 45°C, extracted for 3 hours, filtered, the solid residue was retained, the filtrate was concentrated to a relative density of 1.12, purified with a D001 cation exchange resin column, the eluate of 16 wt% hydrochloric acid solution was collected, extracted with chloroform, and the extract was decompressed to remove the solvent to obtain an alkaloid component;
[0109] The mixed solvent is a mixture of chloroform, ethanol and ammonia water in a volume ratio of 4:2.5:1.1, and the concentration of ammonia water is 21 wt %.
[0110] Comparative Example 2
[0111] Compared with Example 3, the difference is that processed Aconitum kusnezoffii is not added in step S1.
[0112] The details are as follows:
[0113] S1. Preparation of alkaloid component: 21 parts by weight of Sophora flavescens were washed, dried, crushed to obtain powder, added to a mixed solvent, the solid-liquid ratio of the powder to the mixed solvent was 1:5 g / mL, heated to 45°C, extracted for 3 hours, filtered, the solid residue was retained, the filtrate was concentrated to a relative density of 1.12, purified with a D001 cation exchange resin column, and the eluate of 16 wt% hydrochloric acid solution was collected, extracted with chloroform, and the extract was decompressed to remove the solvent to obtain the alkaloid component;
[0114] The mixed solvent is a mixture of chloroform, ethanol and ammonia water in a volume ratio of 4:2.5:1.1, and the concentration of ammonia water is 21 wt %.
[0115] Comparative Example 3
[0116] Compared with Example 3, the difference is that Panax notoginseng is not added in step S5.
[0117] The details are as follows:
[0118] S5. Preparation of saponin component: 7.5 parts by weight of ginseng were washed, dried, crushed, added to 100 parts by weight of water, 2.5 parts by weight of sucrose and 1.5 parts by weight of ammonium nitrate were added, sterilized, inoculated with Lactobacillus casei and Lactobacillus helveticus seed liquid, the inoculation amount was 2.5v / v% and 1.5v / v%, respectively, at 37°C, 170r / min, fermented for 42h, filtered, the solid residue was washed with sterile water, the eluted bacterial liquid was collected, the bacterial liquid was concentrated to obtain a concentrated bacterial liquid, the filtrate was concentrated to a relative density of 1.12, refined with D101 macroporous adsorption resin, 47% of the ethanol eluate was collected, the ethanol was recovered, and dried to obtain the saponin component.
[0119] Comparative Example 4
[0120] Compared with Example 3, the difference is that ginseng is not added in step S5.
[0121] The details are as follows:
[0122] S5. Preparation of saponin component: 7.5 parts by weight of Panax notoginseng were washed, dried, crushed, added to 100 parts by weight of water, 2.5 parts by weight of sucrose and 1.5 parts by weight of ammonium nitrate were added, sterilized, inoculated with Lactobacillus casei and Lactobacillus helveticus seed liquid, the inoculation amount was 2.5v / v% and 1.5v / v%, respectively, at 37°C, 170r / min, fermented for 42h, filtered, the solid residue was washed with sterile water, the eluted bacterial liquid was collected, the bacterial liquid was concentrated to obtain a concentrated bacterial liquid, the filtrate was concentrated to a relative density of 1.12, refined with D101 macroporous adsorption resin, 47% of the ethanol eluate was collected, the ethanol was recovered, and dried to obtain the saponin component.
[0123] Comparative Example 5
[0124] Compared with Example 3, the difference is that the Lactobacillus casei seed liquid is not inoculated in step S5.
[0125] The details are as follows:
[0126] S5. Preparation of saponin component: 6 parts by weight of Panax notoginseng and 1.5 parts by weight of ginseng were washed, dried, crushed, added to 100 parts by weight of water, and then 2.5 parts by weight of sucrose and 1.5 parts by weight of ammonium nitrate were added, sterilized, inoculated with Lactobacillus helveticus seed solution, the inoculation amount was 4v / v%, 37°C, 170r / min, fermented and cultured for 42h, filtered, the solid residue was washed with sterile water, the eluted bacterial solution was collected, the bacterial solution was concentrated to obtain a concentrated bacterial solution, the filtrate was concentrated to a relative density of 1.12, refined with D101 macroporous adsorption resin, 47% of the ethanol eluate was collected, the ethanol was recovered, and dried to obtain the saponin component.
[0127] Comparative Example 6
[0128] Compared with Example 3, the difference is that the Lactobacillus helveticus seed liquid is not inoculated in step S5.
[0129] The details are as follows:
[0130] S5. Preparation of saponin component: 6 parts by weight of Panax notoginseng and 1.5 parts by weight of ginseng were washed, dried, crushed, added to 100 parts by weight of water, and 2.5 parts by weight of sucrose and 1.5 parts by weight of ammonium nitrate were added, sterilized, inoculated with Lactobacillus casei seed liquid, the inoculation amount was 4v / v%, 37°C, 170r / min, fermented and cultured for 42h, filtered, the solid residue was washed with sterile water, the eluted bacterial solution was collected, the bacterial solution was concentrated to obtain a concentrated bacterial solution, the filtrate was concentrated to a relative density of 1.12, refined with D101 macroporous adsorption resin, 47% of the ethanol eluate was collected, the ethanol was recovered, and dried to obtain the saponin component.
[0131] Comparative Example 7
[0132] Compared with Example 3, the difference is that no complex enzyme is added in step S6.
[0133] The details are as follows:
[0134] The details are as follows:
[0135] S6. Fermentation: 6 parts by weight of the solid residue in step S1, 3 parts by weight of the solid residue in step S2, 2.5 parts by weight of the solid residue in step S3, 4 parts by weight of the solid residue in step S4, and 4 parts by weight of the solid residue in step S5 are mixed evenly, added to 1000 parts by weight of water, sterilized, inoculated with the concentrated bacterial solution obtained in step S6, the inoculation amount is 0.7v / v%, 38°C, 170r / min, fermented and cultured for 42h, filtered, the solid was washed with sterile water, the eluted bacterial solution was collected, and freeze-dried to obtain probiotics; 10 parts by weight of sodium copper chlorophyllin was added to 1000 parts by weight of the filtrate, the reaction was stirred for 1h, dialyzed with a pore size of 1.5kD for 4h, and the dialyzate was freeze-dried to obtain a fermentation-sodium copper chlorophyllin product.
[0136] Comparative Example 8
[0137] Compared with Example 3, the difference is that sodium copper chlorophyllin is not added in step S6.
[0138] The details are as follows:
[0139] S6. Enzymatic fermentation: 6 parts by weight of the solid residue in step S1, 3 parts by weight of the solid residue in step S2, 2.5 parts by weight of the solid residue in step S3, 4 parts by weight of the solid residue in step S4, and 4 parts by weight of the solid residue in step S5 are mixed evenly, added to 1000 parts by weight of water, and a composite enzyme is added, wherein the amount of the composite enzyme added is 3wt% of the total mass of the system, enzymatically hydrolyzed at 42°C for 2h, sterilized, inoculated with the concentrated bacterial solution obtained in step S6, the inoculation amount is 0.7v / v%, 38°C, 170r / min, enzymatic fermentation culture is carried out for 42h, filtered, the solid is washed with sterile water, the eluted bacterial solution is collected, and freeze-dried to obtain probiotics; the filtrate is freeze-dried to obtain a fermentation product;
[0140] The complex enzyme is a mixture of cellulase and pectinase, with a mass ratio of 8:3.
[0141] Comparative Example 9
[0142] Compared with Example 3, the difference is that no prebiotics are added in step S8.
[0143] The details are as follows:
[0144] S8. Preparation of embedded particles: 6 parts by weight of the probiotics prepared in step S6 are mixed evenly, added to 170 parts by weight of water, 13 parts by weight of sodium alginate and 0.7 parts by weight of lecithin are added, and stirred for 10 minutes to obtain an aqueous phase; the aqueous phase is added to 320 parts by weight of fish oil, emulsified at 10000 r / min for 10 minutes, 50 parts by weight of 4wt% calcium chloride solution is added dropwise, and cured at room temperature for 25 minutes to obtain embedded particles.
[0145] Comparative Example 10
[0146] Compared with Example 3, the difference is that sulfasalazine is not added in step S9.
[0147] The details are as follows:
[0148] S10. Preparation of a Chinese medicine composition for treating rheumatic bone diseases: 6 parts by weight of the alkaloid component prepared in step S1, 4 parts by weight of the phenylpropanoid component prepared in step S2, 1.5 parts by weight of the volatile oil component prepared in step S3, 4 parts by weight of the gentiana macrophylla extract prepared in step S4, 5 parts by weight of the saponin component prepared in step S5, 8 parts by weight of the fermentation-sodium copper chlorophyll product prepared in step S6, and 13 parts by weight of the embedded particles prepared in step S8 are stirred and mixed for 20 minutes to prepare a Chinese medicine composition for treating rheumatic bone diseases.
[0149] Comparative Example 11
[0150] Compared with Example 3, the difference is that no alkaloid component is added in step S10.
[0151] The details are as follows:
[0152] S10. Preparation of a Chinese medicine composition for treating rheumatic bone diseases: 4 parts by weight of the phenylpropanoid component prepared in step S2, 1.5 parts by weight of the volatile oil component prepared in step S3, 4 parts by weight of the Gentiana macrophylla extract prepared in step S4, 5 parts by weight of the saponin component prepared in step S5, 8 parts by weight of the fermentation-sodium copper chlorophyll product prepared in step S6, and 13 parts by weight of the complex prepared in step S9 are stirred and mixed for 20 minutes to prepare a Chinese medicine composition for treating rheumatic bone diseases.
[0153] Comparative Example 12
[0154] Compared with Example 3, the difference is that no phenylpropanoid component is added in step S10.
[0155] The details are as follows:
[0156] S10. Preparation of a Chinese medicine composition for treating rheumatic bone disease: 6 parts by weight of the alkaloid component prepared in step S1, 1.5 parts by weight of the volatile oil component prepared in step S3, 4 parts by weight of the gentiana macrophylla extract prepared in step S4, 5 parts by weight of the saponin component prepared in step S5, 8 parts by weight of the fermentation-sodium copper chlorophyll product prepared in step S6, and 13 parts by weight of the complex prepared in step S9 are stirred and mixed for 20 minutes to prepare a Chinese medicine composition for treating rheumatic bone disease.
[0157] Comparative Example 13
[0158] Compared with Example 3, the difference is that no volatile oil component is added in step S10.
[0159] The details are as follows:
[0160] S10. Preparation of a traditional Chinese medicine composition for treating rheumatic bone diseases: 6 parts by weight of the alkaloid component prepared in step S1, 4 parts by weight of the phenylpropanoid component prepared in step S2, 4 parts by weight of the gentiana macrophylla extract prepared in step S4, 5 parts by weight of the saponin component prepared in step S5, 8 parts by weight of the fermentation-sodium copper chlorophyll product prepared in step S6, and 13 parts by weight of the complex prepared in step S9 are stirred and mixed for 20 minutes to prepare a traditional Chinese medicine composition for treating rheumatic bone diseases.
[0161] Comparative Example 14
[0162] Compared with Example 3, the difference is that no Gentiana macrophylla extract is added in step S10.
[0163] The details are as follows:
[0164] S10. Preparation of a Chinese medicine composition for treating rheumatic bone diseases: 6 parts by weight of the alkaloid component prepared in step S1, 4 parts by weight of the phenylpropanoid component prepared in step S2, 1.5 parts by weight of the volatile oil component prepared in step S3, 5 parts by weight of the saponin component prepared in step S5, 8 parts by weight of the fermentation-sodium copper chlorophyll product prepared in step S6, and 13 parts by weight of the complex prepared in step S9 are stirred and mixed for 20 minutes to prepare a Chinese medicine composition for treating rheumatic bone diseases.
[0165] Comparative Example 15
[0166] Compared with Example 3, the difference is that no saponin component is added in step S10.
[0167] The details are as follows:
[0168] S10. Preparation of a traditional Chinese medicine composition for treating rheumatic bone diseases: 6 parts by weight of the alkaloid component prepared in step S1, 4 parts by weight of the phenylpropanoid component prepared in step S2, 1.5 parts by weight of the volatile oil component prepared in step S3, 4 parts by weight of the Gentiana macrophylla extract prepared in step S4, 8 parts by weight of the fermentation-sodium copper chlorophyll product prepared in step S6, and 13 parts by weight of the complex prepared in step S9 are stirred and mixed for 20 minutes to prepare a traditional Chinese medicine composition for treating rheumatic bone diseases.
[0169] Comparative Example 16
[0170] Compared with Example 3, the difference is that no fermentation-sodium copper chlorophyllin product is added in step S10.
[0171] The details are as follows:
[0172] S10. Preparation of a traditional Chinese medicine composition for treating rheumatic bone diseases: 6 parts by weight of the alkaloid component prepared in step S1, 4 parts by weight of the phenylpropanoid component prepared in step S2, 1.5 parts by weight of the volatile oil component prepared in step S3, 4 parts by weight of the gentiana macrophylla extract prepared in step S4, 5 parts by weight of the saponin component prepared in step S5, and 13 parts by weight of the complex prepared in step S9 are stirred and mixed for 20 minutes to prepare a traditional Chinese medicine composition for treating rheumatic bone diseases.
[0173] Comparative Example 17
[0174] Compared with Example 3, the difference is that no composite is added in step S10.
[0175] The details are as follows:
[0176] S10. Preparation of a traditional Chinese medicine composition for treating rheumatic bone diseases: 6 parts by weight of the alkaloid component prepared in step S1, 4 parts by weight of the phenylpropanoid component prepared in step S2, 1.5 parts by weight of the volatile oil component prepared in step S3, 4 parts by weight of the gentiana macrophylla extract prepared in step S4, 5 parts by weight of the saponin component prepared in step S5, and 8 parts by weight of the fermentation-sodium copper chlorophyll product prepared in step S6 are stirred and mixed for 20 minutes to prepare a traditional Chinese medicine composition for treating rheumatic bone diseases.
[0177] Test Example 1 Animal Experiment
[0178] Animal Grouping:
[0179] After adaptive feeding for 7 days, SPF SD rats were randomly divided into a normal group, a model group, Example 1-5 groups, Comparative Example 1-17 groups, and a positive drug group, with 8 rats in each group.
[0180] Modeling: Except for the normal control group, rats in other groups were subcutaneously injected with 0.1 mL of Freund's complete adjuvant (10 mg / mL) at the plantar level of the left hind paw to induce inflammation, while the normal group was injected with an equal amount of normal saline.
[0181] Administration: After the modeling was completed, the Example 1-5 group and the Comparative Example 1-17 group were gavaged with 0.5 mg / kg of the Chinese medicine composition for treating rheumatic bone disease prepared in the corresponding group, the normal group and the model group were given an equal volume of distilled water, and the positive drug group was given 150 mg / kg of Yaotongning Capsules (Jingfukang Pharmaceutical Group Co., Ltd.), once a day for 14 consecutive days.
[0182] Plantar swelling:
[0183] After the administration, the thickness of the left hind paw of the rats was measured and the degree of paw swelling was calculated.
[0184] Swelling degree = (C t -C 0 ) / C 0 , C 0 Indicates the thickness of the inflamed forefoot, C t Indicates the thickness of the plantar fossa after inflammation.
[0185] The results are shown in Table 1.
[0186] Table 1
[0187]
[0188]
[0189] Note: * compared with the normal group, P < 0.05; # compared with the model group, P < 0.05.
[0190] It can be seen from the above table that the Chinese medicinal composition for treating rheumatic bone disease prepared in Examples 1-3 of the present invention can significantly reduce the swelling degree of the plantar of rats.
[0191] Rat arthritis index: After the last administration, the primary lesions on the inflamed side of each group of rats were observed and the rat arthritis index was calculated.
[0192] The arthritis index was determined as follows: 0 = normal; 1 = mild but noticeable swelling and redness of the ankle or wrist, or noticeable swelling and redness limited to individual fingers, regardless of the number of fingers affected; 2 = moderate swelling and redness of the ankle or wrist; 3 = severe redness and swelling of the entire paw, including the fingers; 4 = maximal inflammation of the limb, involving multiple joints. The scores of the left and right paw joints were accumulated.
[0193] The results are shown in Table 2.
[0194] Table 2
[0195]
[0196]
[0197] Note: * compared with the normal group, P < 0.05; # compared with the model group, P < 0.05.
[0198] It can be seen from the above table that the Chinese medicinal compositions for treating rheumatic bone diseases prepared in Examples 1-3 of the present invention can significantly reduce the arthritis index of rats.
[0199] Serum levels of tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), prostaglandin E2 (PGE 2 ) levels: After the last administration, the rats were anesthetized, blood was collected from the abdominal aorta, and serum was collected. TNF-α, IL-1β, and PGE 2 level.
[0200] The results are shown in Table 3.
[0201] Table 3
[0202]
[0203]
[0204] Note: * compared with the normal group, P < 0.05; # compared with the model group, P < 0.05.
[0205] As can be seen from the above table, the Chinese medicine composition for treating rheumatic bone disease prepared in Examples 1-3 of the present invention can significantly reduce the levels of TNF-α, IL-1β, PGE 2 level.
[0206] Compared with Example 3, in Examples 4 and 5, the complex enzyme is a single cellulase or pectinase. Compared with Example 3, in Comparative Example 7, no complex enzyme is added in step S6. 2 The addition of compound enzymes can promote the breaking of cell walls of unbroken plant cells in traditional Chinese medicine components, thereby promoting the dissolution of active traditional Chinese medicine components, greatly improving the anti-inflammatory effect, and thus improving the improvement effect on rheumatic bone diseases.
[0207] Compared with Example 3, in Comparative Examples 1 and 2, no Radix Sophorae Flavescentis or Radix Aconiti Kusnezoffii was added in step S1. Compared with Example 3, in Comparative Example 11, no alkaloid component was added in step S10. The swelling degree of the plantar was increased, the arthritis index was increased, and TNF-α, IL-1β, PGE 2 The level of Radix Aconiti Kusnezoffii is improved. The processed Radix Aconiti Kusnezoffii has the effects of dispelling wind and dampness, warming the meridians and relieving pain. Its main ingredients, aconitum alkaloids, including aconitine and neoaconitine, have analgesic, anti-inflammatory, immune-regulating and anti-tumor effects, and inhibit prostaglandin E2 (PGE 2 ) synthesis, reduce capillary permeability, antagonize inflammatory mediators and cytokines, aconitine, neoaconitine, etc. can be used as Na+ Aconitine is an activator of the channel and binds to its channel binding site, causing it to depolarize and block pain transmission. Aconitine can inhibit T cells and their subsets, thereby indirectly inhibiting the differentiation of B cells and exerting a regulatory effect on cellular immunity and humoral immunity. Matrine, an alkaloid in Sophora flavescens, has antiviral, anti-inflammatory and immune regulatory effects. It can reduce the tenderness of patients with rheumatic bone diseases, reduce the level of inflammatory factors, inhibit the phosphatidylinositol 3-kinase / protein kinase B signaling pathway, inhibit collagen-induced arthritis synovial angiogenesis, and promote synovial cell apoptosis.
[0208] Comparative Examples 3 and 4 Compared with Example 3, no notoginseng or ginseng was added in step S5. Comparative Example 15 Compared with Example 3, no saponin component was added in step S10. The swelling degree of the plantar was increased, the arthritis index was increased, and TNF-α, IL-1β, PGE 2 Levels are improved. Panax notoginseng and ginseng are rich in saponins. At the same time, through the fermentation of fermentation bacteria, ordinary saponins can be transformed into highly active rare saponins. Among them, Panax notoginseng saponin R1, ginsenoside Rg1, Rg3, and Rh2 can inhibit the activation of the MAPK / ERK pathway, limit the release of inflammatory factors interleukin-6 (IL-6) and IL-1β, inhibit the synthesis of metalloproteinases in joint tissues, reduce inflammatory reactions, and slow down the degradation of articular cartilage, thereby alleviating the condition of rheumatic bone disease. Panax notoginseng total saponins can slow down the rate of intervertebral disc degeneration by regulating the IL-1β / NF-KB signaling pathway. Under the synergistic effect of Panax notoginseng saponins and ginsenosides, they can play an anti-inflammatory, antibacterial, inhibit platelet aggregation, improve microcirculation, resist free radical damage, resist thrombosis, improve bone and joint microcirculation, and promote injury repair.
[0209] Compared with Example 3, in Comparative Examples 5 and 6, no Lactobacillus casei seed solution or Lactobacillus helveticus seed solution was inoculated in step S5. TNF-α, IL-1β, PGE 2 Levels are improved. Probiotics can help form a thicker mucosal barrier to resist pathogens and inhibit the production of serum amyloid A, tumor necrosis factor α and fibrinogen by regulating the intestinal flora, thereby improving the condition of rheumatic bone disease. Intake of Lactobacillus casei can reduce the secretion of IL-10, tumor necrosis factor α, and IL-12, and intake of Lactobacillus helveticus can significantly reduce antigen-specific IgG levels and inflammatory responses, inhibit the progression of rheumatic bone disease, and further alleviate the condition. The two have a synergistic effect.
[0210] Compared with Example 3, in Comparative Example 8, sodium copper chlorophyllin was not added in step S6. Compared with Example 3, in Comparative Example 16, no fermentation-sodium copper chlorophyllin product was added in step S10. Arthritis index increased, TNF-α, IL-1β, PGE 2Sodium copper chlorophyllin is an antioxidant that helps neutralize free radicals, reduce oxidative stress, protect cells and tissues from oxidative damage, reduce inflammatory responses, relieve discomfort caused by inflammation, and help reduce toxins in the body, including heavy metals and other harmful substances. At the same time, by adding sodium copper chlorophyllin, part of its copper can chelate with active substances such as protein peptides and polysaccharides produced during the fermentation process to form copper-containing protein peptide-polysaccharide chelates, which have excellent antioxidant and anti-inflammatory effects.
[0211] Compared with Example 3, no prebiotics were added in step S8 in Comparative Example 9. The swelling degree of the plantar edema increased, and the arthritis index increased. By adding prebiotics, the intestinal flora structure of patients with rheumatic bone disease can be changed, and the intestinal bacteria can increase the production of short-chain fatty acids such as butyrate and propionate, which has an immunomodulatory effect and can indirectly improve the condition of rheumatic bone disease. In addition, prebiotics, including inulin and carboxymethyl tuckahoe polysaccharide, can also form a shell layer of the embedded particles together with sodium alginate, and enhance the ability of the embedded particles to resist gastric acid and choline, thereby ensuring that the probiotics can smoothly reach the intestines, and the prebiotics are also used by the probiotics in the intestines, thereby playing a good regulatory role.
[0212] Comparative Example 10 Compared with Example 3, sulfasalazine was not added in step S9. The swelling degree of the plantar edema increased, the arthritis index increased, and TNF-α, IL-1β, and PGE 2 The level is improved. Comparative Example 17 Compared with Example 3, no complex is added in step S10. Although the sulfasalazine added in the complex has no direct activity in the intestine, it stimulates the intestinal microbiome gene encoding azoreductase to cut the NN double bond to release active 5-aminosalicylic acid after reaching the distal intestine, achieving anti-inflammatory effect. At the same time, sulfasalazine can induce the expression of intestinal microbiome gene clusters, encoding thioredoxin reductase and nitrate reductase, and thioredoxin reductase can inhibit hydrogen peroxide from inhibiting the apoptosis of synovial cells in patients with rheumatic bone disease, thereby improving the symptoms of joint pain in patients with rheumatic bone disease.
[0213] Comparative Example 12 Compared with Example 3, no phenylpropanoid component was added in step S10. The degree of swelling of the plantar foot increased, and the arthritis index increased. Thick rattan has the effects of dispelling wind and dampness, eliminating carbuncle and dispersing knots, removing toxins and reducing swelling. Among them, the phenylpropanoid components such as eugenol and 4-vinylguaiacol extracted can significantly inhibit the synthesis of prostaglandins, and its anti-inflammatory mechanism may be related to inhibiting leukocyte chemotaxis, preventing leukocytes from producing oxygen free radicals, inhibiting carrageenan-induced swelling of the plantar foot, ear swelling and prostaglandin synthesis in mice, improving rheumatism, coldness, heat arthralgia joint damage, reducing joint swelling, and inhibiting the generation of inflammatory factors in serum.
[0214] Comparative Example 13 Compared with Example 3, no volatile oil component was added in step S10. Arthritis index increased, TNF-α, IL-1β, PGE2 The volatile oil extracted from coix seed and cinnamon bark can promote cellular immunity and humoral immunity, and also has anti-inflammatory effect.
[0215] Comparative Example 14 Compared with Example 3, no Gentiana macrophylla extract was added in step S10. The swelling degree of the plantar increased, the arthritis index increased, and TNF-α, IL-1β, PGE 2 Gentiana macrophylla contains a large amount of gentiopicroside, which can inhibit the ear swelling of mice caused by xylene and the increase in the permeability of the mouse peritoneal capillaries caused by acetic acid. It has a certain inhibitory effect on the early exudation of inflammation and has a sustained analgesic effect. Its dampness-removing effect is beneficial to the excretion of uric acid. At the same time, during the extraction process, gentiopicroside can react with ammonia to obtain the alkaloid gentianine A, which can reduce joint swelling and further improve the anti-rheumatic effect.
[0216] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. A preparation process of a Chinese medicine composition for treating rheumatic bone disease, characterized in that: The specific steps include: S1. Preparation of alkaloid component: 7-10 parts by weight of Sophora flavescens and 12-15 parts by weight of Radix Aconiti Kusnezoffii were washed, dried, and crushed to obtain a mixed powder, which was added to a mixed solvent, wherein the solid-liquid ratio of the mixed powder to the mixed solvent was 1:4-7 g / mL, heated to 40-50°C, extracted for 2-4 hours, filtered, the solid residue was retained, the filtrate was concentrated to a relative density of 1.1-1.15, and purified with a strong acid cation exchange resin column, and the eluent of 12-20wt% hydrochloric acid solution was collected, extracted with chloroform, and the solvent was removed from the extract under reduced pressure to obtain an alkaloid component; The mixed solvent is a mixture of chloroform, ethanol and ammonia water in a volume ratio of 3-5:2-3:1-1.2, and the concentration of ammonia water is 20-22wt%; S2. Preparation of phenylpropanoid components: crush thick vine, add it to 50-60wt% ethanol aqueous solution, the solid-liquid ratio of the thick vine and 50-60wt% ethanol aqueous solution is 1:5-10g / mL, add cellulase, the addition amount is 1-2wt% of the total mass of the system, enzymolysis at 50-55℃ for 0.5-1h, filter, retain the filter residue, recover ethanol from the filtrate, dry, dissolve 10 parts by weight of the product in 100 parts by weight of water, adjust the solution pH to 2.5-3.5, purify with NKA-9 macroporous resin, collect 50% of the ethanol eluate, recover ethanol, dry, and obtain phenylpropanoid components; S3. Preparation of volatile oil component: 2-4 parts by weight of cinnamon, 7-10 parts by weight of coix seed were washed, dried, crushed, subjected to supercritical fluid extraction, the product was recovered by ethanol to obtain a volatile oil component, the solid was retained; The conditions of the supercritical fluid extraction are: extraction pressure: 25-30MPa, extraction temperature: 35-45°C, CO2 flow rate: 7-10L / h, extraction time: 1-3h, the entrainer is ethanol, and the addition amount is 1-2wt%; S4. Preparation of Gentiana macrophylla extract: Wash the Gentiana macrophylla, crush it, add water to mix, the solid-liquid ratio of the Gentiana macrophylla and water is 1:6-8g / mL, boil and extract for 2-4h, filter, retain the solid residue, add ammonia water to the filtrate to adjust the pH value of the solution to 9-10, heat to 40-45°C, stir and react for 0.5-1h, concentrate to a relative density of 1.1-1.15, purify with D101 macroporous adsorption resin, collect 30% and 60% ethanol eluates, combine the eluates, recover ethanol, dry, and obtain Gentiana macrophylla extract; S5. Preparation of saponin component: 5-7 parts by weight of Panax notoginseng and 1-2 parts by weight of ginseng were washed, dried, crushed, added to 100 parts by weight of water, 2-3 parts by weight of carbon source, 1-2 parts by weight of nitrogen source were added, sterilized, inoculated with Lactobacillus casei and Lactobacillus helveticus seed solution, the inoculation amount was 2-3v / v% and 1-2v / v%, respectively, at 36-38°C, 150-200r / min, fermented and cultured for 36-48h, filtered, the solid residue was washed with sterile water, the eluted bacterial solution was collected, the bacterial solution was concentrated to obtain a concentrated bacterial solution, the filtrate was concentrated to a relative density of 1.1-1.15, refined by D101 macroporous adsorption resin, 45-50% of the ethanol eluate was collected, the ethanol was recovered, and dried to obtain a saponin component; The bacterial content of the Lactobacillus casei and Lactobacillus helveticus seed liquid is 10 8 -10 9 cfu / mL; S6. Enzymatic fermentation: 5-7 parts by weight of the solid residue in step S1, 2-4 parts by weight of the solid residue in step S2, 2-3 parts by weight of the solid residue in step S3, 3-5 parts by weight of the solid residue in step S4, and 3-5 parts by weight of the solid residue in step S5 are mixed evenly, added to 1000 parts by weight of water, and a composite enzyme is added, wherein the amount of the composite enzyme added is 2-4wt% of the total mass of the system, enzymolysis is performed at 40-45°C for 1-3h, sterilized, and inoculated with the concentrated bacteria obtained in step S6 liquid, the inoculation amount is 0.5-1v / v%, 37-40°C, 150-200r / min, the enzymatic fermentation culture is carried out for 36-48h, the solid is filtered, the eluted bacterial liquid is collected and freeze-dried to obtain probiotics; 7-12 parts by weight of sodium copper chlorophyllin are added to 1000 parts by weight of the filtrate, the reaction is stirred for 0.5-1h, dialyzed with a dialysis bag with a pore size of 1k-2kD for 3-5h, and the dialyzate is freeze-dried to obtain a fermentation-sodium copper chlorophyllin product; The complex enzyme is a mixture of cellulase and pectinase, with a mass ratio of 7-10:2-4; S7. Preparation of prebiotics: 10-12 parts by weight of inulin and 7-10 parts by weight of carboxymethyl pachymaran were mixed to obtain prebiotics; S8. Preparation of embedded particles: 5-7 parts by weight of the probiotics prepared in step S6 and 3-5 parts by weight of the prebiotics prepared in step S7 are mixed uniformly, added to 150-200 parts by weight of water, 12-15 parts by weight of sodium alginate and 0.5-1 parts by weight of lecithin are added, and stirred to obtain an aqueous phase; the aqueous phase is added to 300-350 parts by weight of fish oil, emulsified, 50 parts by weight of 3-5wt% calcium chloride solution is added dropwise, and cured at room temperature for 20-30min to obtain embedded particles; S9. Preparation of the composite: 20-30 parts by weight of the embedded particles obtained in step S8 and 0.5-1 parts by weight of sulfasalazine were mixed uniformly to obtain a composite; S10. Preparation of a traditional Chinese medicine composition for treating rheumatic bone diseases: 5-7 parts by weight of the alkaloid component prepared in step S1, 3-5 parts by weight of the phenylpropanoid component prepared in step S2, 1-2 parts by weight of the volatile oil component prepared in step S3, 3-5 parts by weight of the gentiana macrophylla extract prepared in step S4, 4-6 parts by weight of the saponin component prepared in step S5, 7-10 parts by weight of the fermentation-sodium copper chlorophyll product prepared in step S6, and 12-15 parts by weight of the complex prepared in step S9 are mixed uniformly to prepare a traditional Chinese medicine composition for treating rheumatic bone diseases.
2. A Chinese medicine composition for treating rheumatic bone disease obtained by the preparation method as claimed in claim 1.
3. Use of the Chinese medicine composition for treating rheumatic bone disease as claimed in claim 2 in the preparation of a medicine for treating or assisting in treating rheumatic bone disease.
